Literature DB >> 6431269

Characterization of antigenic polypeptides of the RNP, Sm and SS-B nuclear antigens from calf thymus.

N Duran, M Bach, P Puigdomenech, J Palau.   

Abstract

Antinuclear autoantibodies are a hallmark of autoimmune diseases. The RNP, Sm and SS-B nuclear antigens from calf thymus in whole tissue, nuclear extracts and fractions have been studied by using different techniques including immunodiffusion, counterimmunoelectrophoresis and protein blotting. Such studies were done in order to obtain a precise characterization of the polypeptide components of those antigens. From our results it can be established that: one 69.8 Kd polypeptide (for whole tissue and nuclei) and a number of well-defined 32-38-Kd polypeptides (for nuclear extracts and ammonium sulfate fractions) show an antigenic character against anti-RNP sera; anti-Sm sera from different patients show in all cases a variable component of antigenic polypeptides, including one 28.8, 29.7 Kd doublet and two singlets of 14.8 and 11.0 Kd; and a 52.0-Kd SS-B antigenic polypeptide is found for whole tissue, which is gradually degraded in nuclei and nuclear extracts to a more stable 47.1-Kd polypeptide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431269     DOI: 10.1016/0161-5890(84)90026-9

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

1.  Heterogeneity of RNP and Sm autoantigens in relation to the cell sources and the activated state of the cells.

Authors:  F Hiepe; K Yamamoto; A Takeuchi; E Apostoloff; T Miyamoto
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  A DNA polymerase from maize axes: its purification and possible role.

Authors:  P Coello; R Rodríquez; E García; J M Vázquez-Ramos
Journal:  Plant Mol Biol       Date:  1992-12       Impact factor: 4.076

3.  The effect of La(SSB) on PWM-induced immunoglobulin synthesis by anti-La(SSB) positive SLE patients and healthy controls.

Authors:  G Smith; C A Morrison; P J Maddison
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.